4//SEC Filing
Bhavnagri Veer 4
Accession 0001214659-21-008761
CIK 0001737287other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:05 PM ET
Size
9.0 KB
Accession
0001214659-21-008761
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2021-08-16$2.27/sh+5,000$11,350→ 426,353 total - Sale
Common Stock
2021-08-16$21.00/sh−5,000$104,994→ 421,353 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-16−5,000→ 117,300 totalExercise: $2.27Exp: 2028-06-25→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.82 to $21.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001808980
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:05 PM ET
- Size
- 9.0 KB